Catalyst Crew Technologies Corp. has appointed Dr. Kevin Rodan Levy as Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer, and Sole Director of the Company, effective February 17, 2026. The leadership transition follows the resignation of the Company's prior officers and directors, as disclosed in a Form 8-K filed with the U.S. Securities and Exchange Commission. This appointment represents a critical juncture for the company as it advances its strategic shift toward artificial intelligence-enabled healthcare technology solutions.
Dr. Rodan brings a unique combination of clinical medical training, healthcare operations experience, and technology platform leadership to his new role. Since 2021, he has served as Chief Executive Officer of Grupo Casamed 18 C.A., where he has been involved in healthcare delivery management and organizational development initiatives. He has also led EmpleUp, a technology-focused human capital and recruitment platform. His background aligns with Catalyst Crew Technologies' focus on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America.
The importance of this leadership transition lies in its timing and strategic implications. Catalyst Crew Technologies is a development-stage enterprise that has not generated revenues from its newly announced business direction. The company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms. Dr. Rodan's appointment signals a focused effort to build operational foundations for this ambitious transformation.
"I am honored to lead Catalyst Crew Technologies Corp. at this pivotal stage in its evolution," said Dr. Rodan. "Our focus is on disciplined execution of the Company's strategic transition into AI-enabled healthcare solutions, with particular emphasis on scalable platforms that address access and efficiency challenges in emerging markets. We are committed to building a strong operational foundation and advancing initiatives that position the Company for long-term sustainable development."
The implications of this announcement extend beyond corporate leadership changes. As an artificial intelligence-driven healthcare technology company, Catalyst Crew Technologies aims to address growing demand for modernized healthcare delivery systems across emerging markets. The company's success or failure in implementing its business plan could influence how AI healthcare solutions are deployed in regions with significant healthcare access challenges. For investors and industry observers, this leadership change represents both opportunity and risk, as the company acknowledges in its forward-looking statements that actual results may differ materially from expectations due to various factors including the Company's ability to successfully implement its business plan, secure financing, complete acquisitions, and comply with regulatory requirements.
The Company intends to continue providing updates through filings with the U.S. Securities and Exchange Commission and other public disclosures as appropriate. For more details about the Company, visit https://catalystcrewai.com, or access its official filings through the U.S. Securities and Exchange Commission website at https://www.sec.gov. The company's strategic direction under new leadership will be closely watched as it attempts to navigate the complex intersection of artificial intelligence, healthcare technology, and emerging market dynamics.
